3/21
01:31 am
gnlx
Low
Report
3/20
11:46 am
gnlx
Genelux (GNLX) had its price target lowered by Benchmark Co. from $23.00 to $20.00. They now have a "speculative buy" rating on the stock.
Low
Report
Genelux (GNLX) had its price target lowered by Benchmark Co. from $23.00 to $20.00. They now have a "speculative buy" rating on the stock.
3/19
04:55 pm
gnlx
Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates [Yahoo! Finance]
Medium
Report
Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates [Yahoo! Finance]
3/19
04:15 pm
gnlx
Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Medium
Report
Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
2/18
08:00 am
gnlx
Genelux Corporation to Participate in Upcoming Conferences
Medium
Report
Genelux Corporation to Participate in Upcoming Conferences
1/12
04:00 pm
gnlx
Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
Medium
Report
Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
1/11
01:03 am
gnlx
Medium
Report
1/8
09:13 am
gnlx
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
Medium
Report
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
1/7
04:12 pm
gnlx
Genelux Corporation Announces Proposed Public Offering of Common Stock [Yahoo! Finance]
High
Report
Genelux Corporation Announces Proposed Public Offering of Common Stock [Yahoo! Finance]
1/7
04:01 pm
gnlx
Genelux Corporation Announces Proposed Public Offering of Common Stock
High
Report
Genelux Corporation Announces Proposed Public Offering of Common Stock
1/5
03:09 pm
gnlx
Genelux (NASDAQ:GNLX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
High
Report
Genelux (NASDAQ:GNLX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/5
08:06 am
gnlx
Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials [Yahoo! Finance]
High
Report
Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials [Yahoo! Finance]
1/5
08:00 am
gnlx
Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials
High
Report
Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials
1/3
01:08 am
gnlx
High
Report
1/2
08:31 am
gnlx
Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer [Yahoo! Finance]
Medium
Report
Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer [Yahoo! Finance]
1/2
08:00 am
gnlx
Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer
Medium
Report
Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer